Ionis Pharmaceuticals Inc (NASDAQ: IONS) slid 0.8% to $46.62. Ionis and Akcea have closed on strategic collaboration with Novartis to develop and commercialize AKCEA-APO(a)-LRx and AKCEA-APOCIII-LRx. Share volume was 1.1 million, compared to an all-day average of 1.8 million
